Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

IgA nephropathy, susceptibility to

MONDO:0100555

An inherited susceptibility or predisposition to developing IgA glomerulonephritis.

16 clinical trials for this condition and its sub-types, 0 tagged with IgA nephropathy, susceptibility to itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Inherited disease susceptibility (1316)

Sub-types of IgA nephropathy, susceptibility to

IgA nephropathy, susceptibility to, 1 16 trials
IgA nephropathy, susceptibility to, 2 0 trials
IgA nephropathy, susceptibility to, 3 0 trials

Including sub-types (16) Tagged with IgA nephropathy, susceptibility to (0)

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 1 Completed 2 Terminated 2

New drug aims to slow kidney disease in IgA nephropathy patients

Disease control Ongoing

This phase 3 trial tests ravulizumab, a drug that blocks part of the immune system, against a placebo in 579 adults with IgA nephropathy—a kidney disease that can lead to kidney failure. The goal is to see if ravulizumab reduces protein in the urine and preserves kidney function …

Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC